Revium Rx (RVRC) Long-Term Deferred Tax (2024 - 2025)
Revium Rx (RVRC) posted Long-Term Deferred Tax of $9.2 million for Q4 2025, up 66.39% sequentially from $5.5 million in Q4 2024, and up 66.39% YoY from $5.5 million in Q4 2024.
Revium Rx (RVRC) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends
Revium Rx has reported Long-Term Deferred Tax for 2 years, with the latest figure at $9.2 million in Q4 2025.
- Quarterly Long-Term Deferred Tax rose 66.39% year-over-year to $9.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.2 million (up 66.39% YoY) and the FY2025 annual result came in at $9.2 million, up 66.39% from the prior year.
- Long-Term Deferred Tax improved to $9.2 million in Q4 2025 per RVRC's latest filing, from $5.5 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $9.2 million in Q4 2025 and troughed at $5.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn |
| 10 | Revium Rx | 101.42 Mn | 99.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.22 Mn |
| Dec 31, 2024 | 5.54 Mn |